Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAFM.L Regulatory News (AFM)

  • There is currently no data for AFM

Form 8.5 (EPT/NON-RI)

10 Jul 2024 11:43

RNS Number : 8916V
BNP Paribas London
10 July 2024
 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN

EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED INTERMEDIARY ("RI") STATUS

(OR WHERE RI STATUS IS NOT APPLICABLE)

Rule 8.5 of the Takeover Code (the "Code")

 

1.

KEY INFORMATION

 

 (a) Name of exempt principal trader:

 

BNP Paribas Financial Markets

 (b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Alpha Financial Markets Consulting plc

 (c) Name of the party to the offer with which exempt principal trader is connected:

Bridgepoint Advisers Limited

 (d) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

09/07/2024

 (e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

No:

 

2.

POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a)

Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

GB00BF16C058 (0.075p ordinary)

 

 

 

Interests

 

Short Positions

 

 

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

443,591

.36

-145,311

-.12

(2) Cash-settled derivatives:

 

0

0

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

0

0

TOTAL:

443,591

.36

-145,311

-.12

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b)

Rights to subscribe for new securities (including directors'' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

3.

DEALINGS BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a)

Purchases and sales

 

Class of

relevant

security

Purchase/

sales

Total number

of securities

Highest price

per unit

paid/received

Lowest price

per unit

paid/received

GB00BF16C058

Sale

-5,235

4.9550 GBP

4.9550 GBP

 

(b)

Cash-settled derivative transactions

 

Class of

relevant

security

Product

description

e.g. CFD

Nature of dealing

e.g. opening/closing a

long/short position

increasing/reducing a

long/short position

Number of

references

securities

Price per

unit

 

 

 

 

 

 

 

 

 

 

 

(c)

Stock-settled derivative transactions (including options)

 

(i)

Writing, selling, purchasing or varying

 

Class

of

relevant

security

Product

description

e.g. call

option

Writing,

purchasing,

selling,

varying etc.

Number

of

securities

to which

option

relates

Exercise

price

per unit

Type

e.g.

American

European

etc.

Expiry

date

Option

money

paid/

received

per unit

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(ii)

Exercise

 

Class of

relevant

security

Product

description

e.g. call option

Exercising/

exercised

against

Number of

securities

Exercise price

per unit

 

 

 

 

 

 

 

 

 

 

 

(d)

Other dealings (including subscribing for new securities)

 

Class of relevant

security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if

applicable)

 

 

 

 

 

 

 

 

 

4.

Other Information

 

(a)

Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b)

Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which

any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c)

Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

 

No

 

 

Date of Disclosure:

 

10/07/2024

Contact Name

 

Compliance Control Room

Telephone Number:

 

0207 595 9695

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEOEAEXEFLALEFA
Date   Source Headline
11th May 202011:15 amRNSHolding(s) in Company
9th Apr 20207:00 amRNSPre-close trading update
1st Apr 20209:12 amRNSHolding(s) in Company
24th Mar 20207:00 amRNSStatement regarding COVID-19
14th Jan 202012:00 pmRNSGrant of incentive awards and total voting rights
2nd Dec 20199:16 amRNSHolding(s) in Company
29th Nov 201911:46 amRNSHolding(s) in Company
25th Nov 20194:19 pmRNSHolding(s) in Company
22nd Nov 20199:50 amRNSDirector/PDMR Shareholding
20th Nov 20197:00 amRNSINTERIM RESULTS
11th Nov 20197:00 amRNSAcquisition of Obsidian Solutions Limited
28th Oct 20198:53 amRNSHolding(s) in Company
24th Oct 201910:27 amRNSHolding(s) in Company
24th Oct 201910:22 amRNSHolding(s) in Company
9th Oct 20197:00 amRNSPre-close trading update
4th Sep 20193:30 pmRNSAGM Statement
5th Aug 20193:37 pmRNSAnnual Report & Accounts and Notice of AGM
24th Jul 20194:00 pmRNSHolding(s) in Company
10th Jul 20195:30 pmRNSHolding(s) in Company
21st Jun 20192:30 pmRNSHolding(s) in Company
19th Jun 20197:00 amRNSStaff Incentive Awards and PDMR Shareholding
5th Jun 20197:15 amRNSAcquisition of Axxsys Limited
5th Jun 20197:00 amRNSFinal Results
3rd Jun 201910:00 amRNSNotice of Results - updated presentation time
11th Apr 20197:00 amRNSPre-close trading update
25th Jan 20198:00 amRNSGrant of incentive awards and Total Voting Rights
14th Jan 20195:30 pmRNSFaroe Petroleum
6th Dec 20185:26 pmRNSGrant of JSOP, PDMR and Total Voting Rights
30th Nov 20185:56 pmRNSHolding(s) in Company
30th Nov 20185:37 pmRNSHolding(s) in Company
30th Nov 20187:00 amRNSDirector/PDMR Shareholding
27th Nov 201810:23 amRNSDividend update
26th Nov 20184:47 pmRNSHolding(s) in Company
26th Nov 20182:05 pmRNSHolding(s) in Company
21st Nov 20187:00 amRNSHalf-year Report
6th Nov 20183:18 pmRNSHolding(s) in Company
16th Oct 20184:45 pmRNSDirector/PDMR Shareholding
11th Oct 20187:00 amRNSPre-close trading update
5th Sep 20182:41 pmRNSResult of AGM
8th Aug 20187:00 amRNSAnnual Review, Annual Report and Notice of AGM
30th Jul 20189:29 amRNSEmployee Incentive Plan and Grant of Awards
6th Jul 201810:30 amRNSNOTIFICATION OF MAJOR HOLDINGS
4th Jul 20184:00 pmRNSDirector/PDMR Shareholding
21st Jun 201810:20 amRNSNOTIFICATION OF MAJOR HOLDINGS
6th Jun 20187:21 amRNSFull Year Results
31st May 201810:33 amRNSNotice of Results
20th Apr 20183:15 pmRNSNotice of Results
6th Mar 20184:00 pmRNSGrant of Share Award - PDMR dealing
1st Mar 20187:00 amRNSTrading Update
28th Feb 20184:35 pmRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.